ES552431A0 - Procedimiento para preparar plasmidos de expresion prhw11 y prhw12 - Google Patents

Procedimiento para preparar plasmidos de expresion prhw11 y prhw12

Info

Publication number
ES552431A0
ES552431A0 ES552431A ES552431A ES552431A0 ES 552431 A0 ES552431 A0 ES 552431A0 ES 552431 A ES552431 A ES 552431A ES 552431 A ES552431 A ES 552431A ES 552431 A0 ES552431 A0 ES 552431A0
Authority
ES
Spain
Prior art keywords
prhw11
prhw12
procedure
expression plasmids
preparing expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES552431A
Other languages
English (en)
Other versions
ES8708013A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3428370A external-priority patent/DE3428370A1/de
Priority claimed from DE19853505060 external-priority patent/DE3505060A1/de
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of ES8708013A1 publication Critical patent/ES8708013A1/es
Publication of ES552431A0 publication Critical patent/ES552431A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Electrotherapy Devices (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ES552431A 1984-08-01 1986-02-26 Procedimiento para preparar plasmidos de expresion prhw11 y prhw12 Expired ES8708013A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3428370A DE3428370A1 (de) 1984-08-01 1984-08-01 Interferon, genetische sequenzen, die hierfuer codieren, und diese produzierende organismen
DE19853505060 DE3505060A1 (de) 1985-02-14 1985-02-14 Neue interferone vom typ i, genetische sequenzen, die hierfuer codieren, und diese produzierende organismen

Publications (2)

Publication Number Publication Date
ES8708013A1 ES8708013A1 (es) 1987-09-01
ES552431A0 true ES552431A0 (es) 1987-09-01

Family

ID=25823496

Family Applications (2)

Application Number Title Priority Date Filing Date
ES545725A Expired ES8609475A1 (es) 1984-08-01 1985-07-30 Procedimiento para preparar peptidos de interferon
ES552431A Expired ES8708013A1 (es) 1984-08-01 1986-02-26 Procedimiento para preparar plasmidos de expresion prhw11 y prhw12

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES545725A Expired ES8609475A1 (es) 1984-08-01 1985-07-30 Procedimiento para preparar peptidos de interferon

Country Status (21)

Country Link
EP (1) EP0170204B1 (es)
JP (2) JP2566909B2 (es)
KR (1) KR0136799B1 (es)
AT (1) ATE67786T1 (es)
AU (1) AU600653B2 (es)
BG (1) BG60445B2 (es)
CA (1) CA1340184C (es)
DD (1) DD246318A5 (es)
DE (1) DE3584198D1 (es)
DK (1) DK175194B1 (es)
ES (2) ES8609475A1 (es)
FI (1) FI90667C (es)
GR (1) GR851866B (es)
HK (1) HK187896A (es)
HU (1) HU205779B (es)
IE (1) IE58942B1 (es)
IL (1) IL75963A (es)
MX (1) MX9203645A (es)
NO (1) NO177863C (es)
NZ (1) NZ212937A (es)
PT (1) PT80901B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231176A (en) * 1984-08-27 1993-07-27 Genentech, Inc. Distinct family DNA encoding of human leukocyte interferons
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
EP0490233A1 (de) * 1986-03-10 1992-06-17 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Monoclonale Antikörper gegen BgIII-Hybridinterferone, deren Verwendung und Verfahren zu ihrer Herstellung
US4863727A (en) * 1986-04-09 1989-09-05 Cetus Corporation Combination therapy using interleukin-2 and tumor necrosis factor
DE3633323A1 (de) * 1986-10-01 1988-04-07 Boehringer Ingelheim Int Neue monoklonale antikoerper gegen ifn-omega, verfahren zu ihrer herstellung und deren verwendung zur reinigung sowie zum nachweis von ifn-omega
DE3635867A1 (de) * 1986-10-22 1988-05-11 Boehringer Ingelheim Int Neue hefeexpressionsvektoren fuer ifn-omega, verfahren zu ihrer herstellung und deren verwendung
CA2641217A1 (en) 1997-11-20 1999-06-03 Vical Incorporated Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
WO2000040273A2 (en) * 1999-01-08 2000-07-13 Vical Incorporated Treatment of viral diseases using an interferon omega expressing polynucleotide
WO2004099231A2 (en) 2003-04-09 2004-11-18 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
US20050287628A1 (en) 2002-03-07 2005-12-29 Markus Aebi System and method for the production of recombinant glycosylated proteins in a prokaryotic host
CA2818688A1 (en) * 2002-03-07 2003-09-12 Eidgenossische Technische Hochschule Zurich System and method for the production of recombinant glycosylated proteins in a prokaryotic host
WO2004096852A1 (fr) * 2003-04-25 2004-11-11 The Institute Of Microbiology And Epidemiology, Academy Of Military Medical Sciemces, Pla Interferon$g(v) humain recombinant, son procede d'expression et ses utilisations
AU2006245969B8 (en) 2005-05-11 2011-08-25 Eth Zurich Recombinant N-glycosylated proteins from procaryotic cells
US8895014B2 (en) 2008-02-20 2014-11-25 Glycovaxyn Ag Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cells
AU2010322454B2 (en) 2009-11-19 2016-05-19 Glaxosmithkline Biologicals S.A. Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells
CN103079591B (zh) 2010-05-06 2017-07-28 格林考瓦因有限公司 荚膜革兰氏阳性细菌生物缀合物疫苗
WO2013024158A1 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of protein kinase inhibitors and interferons or of protein kinase inhibitors and direct acting antivirals for the treatment and the prevention of hcv infection
WO2013024156A2 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of anti-hcv-entry factor antibodies and interferons for the treatment and the prevention of hcv infection
WO2014033266A1 (en) 2012-08-31 2014-03-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Anti-sr-bi antibodies for the inhibition of hepatitis c virus infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1217440A (en) * 1982-08-18 1987-02-03 Michael A. Innis INTERFERON .alpha. 6L
AU1946283A (en) * 1982-08-18 1984-03-07 Cetus Corporation Interferon-alpha 6l
DE3247922A1 (de) * 1982-12-24 1984-06-28 Boehringer Ingelheim International GmbH, 6507 Ingelheim Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
ATE47864T1 (de) * 1984-08-27 1989-11-15 Genentech Inc Verschiedenartige familie von menschlichen leukozyten-interferonen, zusammensetzungen, die diese enthalten, verfahren zu ihrer herstellung, sowie dna und transfektierte wirte hierfuer.

Also Published As

Publication number Publication date
ATE67786T1 (de) 1991-10-15
KR870001310A (ko) 1987-03-13
JPS61181381A (ja) 1986-08-14
JP2566909B2 (ja) 1996-12-25
GR851866B (es) 1985-12-02
FI852956L (fi) 1986-02-02
DD246318A5 (de) 1987-06-03
DK346385A (da) 1986-02-02
AU600653B2 (en) 1990-08-23
HUT39477A (en) 1986-09-29
DK346385D0 (da) 1985-07-30
IE851906L (en) 1986-02-01
HU205779B (en) 1992-06-29
AU4554985A (en) 1986-02-06
FI90667B (fi) 1993-11-30
NO853012L (no) 1986-02-03
JPH06181771A (ja) 1994-07-05
DK175194B1 (da) 2004-07-05
PT80901B (pt) 1989-01-17
ES8708013A1 (es) 1987-09-01
BG60445B2 (bg) 1995-03-31
HK187896A (en) 1996-10-18
NZ212937A (en) 1991-08-27
NO177863B (no) 1995-08-28
ES545725A0 (es) 1986-08-01
KR0136799B1 (ko) 1998-04-25
JP2567195B2 (ja) 1996-12-25
PT80901A (de) 1985-09-01
NO177863C (no) 1995-12-06
MX9203645A (es) 1992-09-01
CA1340184C (en) 1998-12-15
EP0170204A2 (de) 1986-02-05
IL75963A0 (en) 1985-12-31
IL75963A (en) 1992-05-25
EP0170204A3 (en) 1988-02-17
FI852956A0 (fi) 1985-07-31
IE58942B1 (en) 1993-12-01
DE3584198D1 (de) 1991-10-31
EP0170204B1 (de) 1991-09-25
FI90667C (fi) 1994-03-10
ES8609475A1 (es) 1986-08-01

Similar Documents

Publication Publication Date Title
ES552431A0 (es) Procedimiento para preparar plasmidos de expresion prhw11 y prhw12
ES2155819T3 (es) Inmunoglobulinas hibridas.
ES2142363T3 (es) Materiales y metodos para la hipersecrecion de aminoacidos.
EP0293443A4 (en) PREPARATION OF SYNTHETIC DNA AND THEIR USE IN THE SYNTHESIS OF LARGE POLYPEPTIDES.
GR78180B (es)
DE3585953D1 (de) Dna-fragmente, expressionsvektoren, proteine, wirte und verfahren zur herstellung der proteine.
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
DK453782A (da) Dna-sekvenser, rekombinant plasmid samt anvendelser deraf
DE69030615D1 (de) Neue Polypeptide, DNA-Sequenzen, die deren Expression erlauben, Verfahren zur Vorbereitung und Verwendung
DK38889D0 (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
DE68917520D1 (de) Verfahren und Systeme zur Herstellung von HIV-Antigenen.
SG134394G (en) Genetic sequences, type I interferon peptide coded by them, and these organisms producing the same
ATE83800T1 (de) Rekombinantes dns-plasmid zur herstellung von xanthangummi.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20070625